Article in Animals : an open access journal from MDPI, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 51% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 3 institutions in 2 countries.
Lucas Victor Pereira de FreitasDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirao Preto 14040-900, SP, Brazil.ORCID 0000-0001-7183-9362
Carlos Augusto Alvarenga da Mota JúniorDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirao Preto 14040-900, SP, Brazil.
Marina Alves DamacenoDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirao Preto 14040-900, SP, Brazil.
Juliana Grell Fernandes SilveiraDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirao Preto 14040-900, SP, Brazil.ORCID 0000-0002-4540-3378
Ana Carolina Vellosa PortelaDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirao Preto 14040-900, SP, Brazil.
Sarah Chagas CampanharoDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirao Preto 14040-900, SP, Brazil.ORCID 0000-0002-0316-9704
Agnaldo Fernando Baldo da SilvaDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirao Preto 14040-900, SP, Brazil.
Inácio Mateus AssaneLaboratory of Microbiology and Parasitology of Aquatic Organisms, Aquaculture Center of Unesp, Sao Paulo State University (Unesp), Jaboticabal 14884-900, SP, Brazil.ORCID 0000-0002-1830-9845
Fabiana PilarskiLaboratory of Microbiology and Parasitology of Aquatic Organisms, Aquaculture Center of Unesp, Sao Paulo State University (Unesp), Jaboticabal 14884-900, SP, Brazil.ORCID 0000-0003-3263-3235
James Jacob SasanyaInternational Atomic Energy Agency, A-1400 Vienna, Austria.
Jonas Augusto Rizzato PaschoalDepartment of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirao Preto 14040-900, SP, Brazil.ORCID 0000-0002-7372-0936
Universidade de São Paulo · BRUniversidade Estadual Paulista (Unesp) · BRInternational Atomic Energy Agency · AT
Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001International Atomic Energy Agency 24019São Paulo Research Foundation 12/18334-0São Paulo Research Foundation 16/16593-9São Paulo Research Foundation 18/05536-0São Paulo Research Foundation 19/06159-8São Paulo Research Foundation 19/22775-0São Paulo Research Foundation 21/03294-1São Paulo Research Foundation 21/08152-0
6 · The paper itself
Abstract
Sulfadimethoxine (SDM) and ormetoprim (OMP) are antimicrobials used in combination to treat bacterial infections in fish farming. The use of this drug combination is not yet regulated in some countries, such as Brazil. Due to the lack of regulated drugs for aquaculture in Brazil, this study investigated the residue depletion profile of SDM and OMP in Nile tilapia (
Indexed as
aquaculturefood safetyLC-MS/MSQuEChERStilapiaveterinary drug residueswithdrawal period
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Residue Depletion Profile and Estimation of Withdrawal Period for Sulfadimethoxine and Ormetoprim in Edible Tissues of Nile Tilapia ( · full record | OpenQuestion